UBS Group’s Barinthus Biotherapeutics BRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$1.7K Sell
2024
Q2
$121K Buy
2024
Q1
$3.68K Hold
2023
Q4
$5.71K Buy
2023
Q3
$275 Sell
2023
Q2
$2.05K Buy
2023
Q1
Sell
2022
Q4
$8.81K Sell
2022
Q3
$17K Buy
2022
Q2
$2K Sell
2022
Q1
$10K Buy
2021
Q4
$6K Buy